Aligos Therapeutics, Inc. (ALGS) › Shareholders' EquityAligos Therapeutics, Inc. (ALGS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$13.75M2019: -$64.89M2020: $220.04M2021: $184.73M2022: $103.90M2023: $92.08M2024: -$28.97M2025: $53.55M$53.55M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$53.55M+284.8%2024-$28.97M-131.5%2023$92.08M-11.4%2022$103.90M-43.8%2021$184.73M-16.0%2020$220.04M+439.1%2019-$64.89M-372.0%2018-$13.75M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share